Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
24.00    -1.00 (-4.00%)
Bid:
23.00
Ask:
25.00
Spread: 2.00 (8.696%)
Market Cap: £25.92m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

10 Nov 2015 07:00

RNS Number : 1029F
Elektron Technology PLC
10 November 2015
 

Elektron Technology plc

(AIM: EKT, "Elektron" or the "Company" or the "Group")

 

Trading update and launch of new product

Elektron Technology plc , the global technology group, provides an update on third quarter trading.

Trading has continued the pattern of the first half of the financial year. Sales of products from brands in which the Group continues to invest strategically through new product development, namely Bulgin, Queensgate and Ophthalmic, are showing growth over the prior year. Bulgin is showing modest growth while Queensgate and Ophthalmic are in aggregate showing around 50% growth against prior year and now represent around 7.0% of total Group sales. The remaining brands that still account for a majority of the Group's sales are in low growth or declining markets, are experiencing weak demand and continue to track at levels below last year. This is expected to continue through the final quarter of the year. The Group is intensifying its cost cutting measures as a result.

The higher margin sales of products from invested brands, coupled with operational and overhead improvements implemented during the last 18 months, lead the Board to expect that the full year trading performance will be ahead of last year for existing businesses excluding Checkit which is effectively a start-up and is accounted for separately. 

The Board is pleased to confirm that the Checkit Work Management launch was on time and, despite the scale and complexity of the development, broadly in line with estimated development costs. The Group remains on track to launch a significant further enhancement to Checkit's product offering early next year.

Elektron remains committed to its twin strategies of delivering efficiency and productivity improvements in its established businesses and investing in new product development to generate future growth.

Group net debt was approximately £1.5m at 31 October (31 July 2015: £2.1m; 31 January 2015: £2.7m; 31 October 2014: £2.7m). It is anticipated that given the traditional profile of sales, debt levels are unlikely to fall further in the last quarter and may show a slight rise due to working capital movements. The Board is particularly pleased to note that the Group continues both to reduce debt at the same time as investing in new products.

John Wilson, Chief Executive of Elektron, said:

"Although we are somewhat cautious about the trading outlook given current market conditions, performance has so far held up well. We were greatly encouraged by the market reaction to the new Checkit Work Management system at its launch a few weeks ago. The task now is to convert the strong interest into orders. We expect to announce further new product launches shortly."

For further information:

 

Elektron Technology www.elektron-technology.com

+44 (0)1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

 

finnCap (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

 

Notes to Editors

 

Elektron conceives, designs and markets innovative engineered products and services for businesses that connect, monitor and control

 

We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

-- New waves of "aware" business applications: Checkit

-- Demand for ubiquitous power and data: Bulgin

-- Growth in high precision manufacture: Queensgate

 

In addition, Elektron owns a portfolio of well-established products and brands that provide cash flow as well as customer access and feedback

Forward looking statements

Statements contained in this trading statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSAFWUFISEFF
Date   Source Headline
10th Jun 20219:16 amRNSPDMR Dealing
7th Jun 20217:00 amRNSAppointment of Non-Executive Director
3rd Jun 202112:25 pmRNSResult of AGM
13th May 20217:00 amRNSTrading Update
10th May 202112:23 pmRNSPosting of Annual Report and Notice of AGM
4th May 20214:02 pmRNSDirector Dealing
29th Apr 202110:00 amRNSBoard Changes
29th Apr 20217:00 amRNSPreliminary Results
21st Apr 20217:00 amRNSProduct update announcement
23rd Mar 20213:54 pmRNSHolding(s) in Company
22nd Mar 202112:33 pmRNSHolding(s) in Company
19th Mar 20217:00 amRNSElectronic Communications
22nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Feb 20217:00 amRNSGrant of options and PDMR dealings
11th Feb 20217:00 amRNSTrading Update
4th Feb 20217:00 amRNSAcquisition and Business Development Appointments
21st Dec 20205:14 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSDirector Dealing, Exercise of Options and TVR
2nd Dec 20207:00 amEQSCheckit (CKT): Initiation - Smarter operations management
2nd Dec 20207:00 amRNSEdison Investment Research Initiates Coverage
1st Dec 20202:30 pmEQSCheckit (CKT): Initiation - Smarter operations management
10th Nov 20207:00 amRNSTrading Update
19th Oct 20207:00 amRNSContract with John Lewis
24th Sep 20207:00 amRNSBoard Changes
21st Sep 20204:27 pmRNSPDMR Dealing
16th Sep 20207:00 amRNSHalf Year Results
12th Aug 20207:00 amRNSTrading update and notice of interim results
6th Aug 20207:00 amRNSBoard Changes
31st Jul 20201:54 pmRNSResult of AGM
9th Jul 20203:38 pmRNSPDMR Dealing
7th Jul 202010:34 amRNSGrant of share options and PDMR dealings
7th Jul 20207:38 amRNSPosting of Annual Report and Notice of AGM
6th Jul 20207:00 amRNSAppointment of CFO designate
1st Jul 202012:40 pmRNSDisposal of assets
16th Jun 20207:00 amRNSPreliminary Results
2nd Jun 20204:15 pmRNSChange to AGM date and arrangements
26th May 20207:00 amRNSCOVID-19 Update and Change to Results Date
5th May 20205:03 pmRNSResignation of Director
21st Apr 20203:20 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20206:11 pmRNSDirector/PDMR Shareholding
18th Mar 20205:15 pmRNSDirector/PDMR Shareholding
21st Feb 20204:41 pmRNSSecond Price Monitoring Extn
21st Feb 20204:35 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSDirector/PDMR Shareholding
14th Feb 20207:00 amRNSPDMR Dealing and Concert Party Holdings
13th Feb 20207:00 amRNSTrading Update
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
23rd Dec 20195:05 pmRNSHolding(s) in Company
18th Dec 20196:25 pmRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.